Ritonavir and Mometasone furoate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported only by a few people who take Ritonavir and Mometasone furoate together.

The phase IV clinical study analyzes what interactions people who take Ritonavir and Mometasone furoate have. It is created by eHealthMe based on reports of 3 people who take the same drugs from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On May, 26, 2023

3 people who take Ritonavir and Mometasone furoate together, and have interactions are studied.


What is Ritonavir?

Ritonavir has active ingredients of ritonavir. eHealthMe is studying from 11,309 Ritonavir users for its effectiveness, alternative drugs and more.

What is Mometasone furoate?

Mometasone furoate has active ingredients of mometasone furoate. It is often used in asthma. eHealthMe is studying from 8,110 Mometasone furoate users for its effectiveness, alternative drugs and more.

Number of Ritonavir and Mometasone furoate reports submitted per year:

Ritonavir and Mometasone furoate drug interactions.

Common Ritonavir and Mometasone Furoate drug interactions by gender *:

female:

  1. Cushing's syndrome

male:

  1. Anhedonia
  2. Anxiety
  3. Gait disturbance
  4. Hypovitaminosis
  5. Intervertebral disc protrusion
  6. Mobility decreased
  7. Nerve compression
  8. Osteoarthritis
  9. Osteopenia
  10. Quality of life decreased

Common Ritonavir and Mometasone Furoate drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anhedonia
  2. Ankle fracture
  3. Mobility decreased
  4. Nerve compression
  5. Osteoporosis
  6. Pain
  7. Quality of life decreased
  8. Anxiety
  9. Chronic kidney disease
  10. Cushing's syndrome

60+:

n/a

* Approximation only. Some reports may have incomplete information.

Do you take Ritonavir and Mometasone furoate?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Ritonavir and Mometasone furoate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ritonavir side effects:

Browse all side effects of Ritonavir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Mometasone furoate side effects:

Browse all side effects of Mometasone furoate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ritonavir interactions:

Browse all interactions between Ritonavir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Mometasone furoate interactions:

Browse all interactions between Mometasone furoate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ritonavir and mometasone furoate (the active ingredients of Ritonavir and Mometasone furoate, respectively), and Ritonavir and Mometasone furoate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Ritonavir and Mometasone furoate.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: